Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Endovia Health Sciences, Inc.SBEV · Entity 8508 | Director · CEO and Chairman · 10% owner | July 31, 2025 | October 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Endovia Health Sciences, Inc.
Report date July 31, 2025 · Filed October 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.80 · Expires 2030-07-31 | Direct | 750,000 |
Reported balance
After 2025-07-31 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-07-31 · Grant · Acquired 750,000 · Balance 750,000 F1: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2025 Filed Oct 15, 2025 20:20 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants · Derivative | 750,000 | Not disclosed Strike: $0.80 | Not disclosed |
DisclosureSEC source: 0001731122-25-001386 · ownership.xml · derivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2030-07-31 F1 · security: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025. F1 · price: The grant of the Issuer's warrants was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The warrants shall vest as follows: one third upon completion of the repayment by the Company of the UpTime Investors and the other two thirds vesting quarterly over a two-year period with the first vesting date on October 31, 2025. Read SEC document |
| March 05, 2024 Filed Oct 15, 2025 20:18 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001731122-25-001385 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,053 F1 · security: The grant of the Issuer's restricted common stock was exempt from Section 16(b) of the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder, as it was approved by the Issuer's Board of Directors. The shares of restricted common stock are fully vested. F2 · shares: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F2 · balance_after: Gives effect to a reverse stock split of 1-for-40 effective March 27, 2025. F3 · balance_after: The amount beneficially owned will not reconcile to prior Form 4s due to a scriveners error. Read SEC document |
| June 16, 2023 Filed Jun 16, 2023 15:19 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 7,000 | $1.01 | $7,070.00 |
DisclosureSEC source: 0001731122-23-001152 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,386,000 Read SEC document |
| April 14, 2023 Filed Apr 14, 2023 14:34 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 12,000 | $1.15 | $13,788.00 |
DisclosureSEC source: 0001731122-23-000653 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,379,000 Read SEC document |
| April 13, 2023 Filed Apr 13, 2023 16:48 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 10,000 | $1.17 | $11,699.00 |
DisclosureSEC source: 0001731122-23-000644 · ownership.xml · nonDerivative · entry 2 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,367,000 Read SEC document |
| April 13, 2023 Filed Apr 13, 2023 16:48 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 7,000 | $1.17 | $8,183.00 |
DisclosureSEC source: 0001731122-23-000644 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,357,000 Read SEC document |
| June 16, 2022 Filed Jun 16, 2022 21:04 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 1,000 | $1.69 | $1,690.00 |
DisclosureSEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 5 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,327,070 Read SEC document |
| June 16, 2022 Filed Jun 16, 2022 21:04 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 1,000 | $1.67 | $1,670.00 |
DisclosureSEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 4 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,326,070 Read SEC document |
| June 16, 2022 Filed Jun 16, 2022 21:04 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 1,000 | $1.69 | $1,690.00 |
DisclosureSEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 3 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,325,070 Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:04 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 685 | $1.83 | $1,253.55 |
DisclosureSEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 2 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,324,070 Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:04 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 315 | $1.82 | $573.30 |
DisclosureSEC source: 0001731122-22-001089 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,323,385 Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 13:09 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 1,000 | $2.07 | $2,070.00 |
DisclosureSEC source: 0001731122-22-001037 · ownership.xml · nonDerivative · entry 2 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,323,070 Read SEC document |
| June 03, 2022 Filed Jun 7, 2022 13:09 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 1,000 | $2.04 | $2,040.00 |
DisclosureSEC source: 0001731122-22-001037 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322,070 Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:05 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 1,000 | $2.04 | $2,040.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 7 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,321,070 Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:05 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 1,000 | $2.03 | $2,030.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 6 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320,070 Read SEC document |
| May 27, 2022 Filed May 31, 2022 20:05 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 2,000 | $2.12 | $4,240.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 5 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,319,070 Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:05 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 2,000 | $1.95 | $3,900.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 4 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,317,070 Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:05 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 2,000 | $1.95 | $3,900.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 3 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,315,070 Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:05 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 2,000 | $1.99 | $3,980.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 2 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,313,070 Read SEC document |
| May 26, 2022 Filed May 31, 2022 20:05 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | PurchaseCommon Stock | 1,000 | $1.94 | $1,940.00 |
DisclosureSEC source: 0001731122-22-001019 · ownership.xml · nonDerivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,311,070 Read SEC document |
| September 30, 2021 Filed Apr 1, 2022 01:39 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantOption (Right to Buy) · Derivative | 530,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001731122-22-000653 · ownership.xml · derivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO, President and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,000 Underlying: Common Stock · 530,000 shares Expires 2026-09-30 F1 · derivative.exercise_date: Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022. Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:34 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants (Right to Buy ) · Derivative | 500,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001063 · ownership.xml · derivative · entry 6 Nistico Robert · CIK 0001797597 · Director · CEO, President and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2027-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:34 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants (Right to Buy ) · Derivative | 500,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001063 · ownership.xml · derivative · entry 5 Nistico Robert · CIK 0001797597 · Director · CEO, President and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2026-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:34 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants (Right to Buy ) · Derivative | 1,000,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001063 · ownership.xml · derivative · entry 4 Nistico Robert · CIK 0001797597 · Director · CEO, President and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2025-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:34 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants (Right to Buy ) · Derivative | 333,333 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001063 · ownership.xml · derivative · entry 3 Nistico Robert · CIK 0001797597 · Director · CEO, President and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,333 Underlying: Common Stock · 333,333 shares Expires 2027-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:34 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants (Right to Buy ) · Derivative | 333,333 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001063 · ownership.xml · derivative · entry 2 Nistico Robert · CIK 0001797597 · Director · CEO, President and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,333 Underlying: Common Stock · 333,333 shares Expires 2026-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 22:34 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants (Right to Buy ) · Derivative | 333,334 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001063 · ownership.xml · derivative · entry 1 Nistico Robert · CIK 0001797597 · Director · CEO, President and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,334 Underlying: Common Stock · 333,334 shares Expires 2025-10-15 F1 · price: Not applicable Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.